IP Library Granted Patent US 9,389,182
Granted Patent B2
US 9,389,182 · App. 13/600,908 · Granted Jul 12, 2016

Labeling of proteins with the fluorophore 7-amino-4-methylcoumarin (AMC) generated novel proteolytic substrates

Inventors: Kelvin J. A. Davies (Pasadena, CA); Andrew M. Pickering (Los Angeles, CA)
Assignee: University of Southern California
G01N21/64G01N21/6428
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,389,182
App. No.
13/600,908
Granted
Jul 12, 2016
Kind
B2
Abstract

A method of measuring the degradation of intact proteins includes a step of providing a protein substrate having one or more free or exposed carboxyl groups and then reductively attaching 7-amino-4-methylcoumarin (AMC) to the protein substrate with a reducing agent. The protein substrate is contacted in a test solution with one or more proteolytic enzymes that degrade the protein substrate. The amount of AMC attached to the protein substrate is then determined by monitoring the fluorescence of free 7-amino-4-methylcoumarin that is formed during degradation of the protein substrate to protein fragments.

Claims (29)

1. A method for measuring degradation of intact proteins, the method comprising:

a) reductively attaching 7-amino-4-methylcoumarin (AMC) to a protein substrate with a reducing agent, the reducing agent being sodium cyanoborohydride (NaCNBH 3 ) to form an AMC attached protein;

b) contacting in a test solution the AMC attached protein substrate with a proteolytic enzyme that degrade the protein substrate into protein fragments; and

c) measuring fluorescence during degradation of the AMC attached protein substrate.

2. The method of claim 1 wherein the fluorescence measured in step c) is compared to a standard curve of known concentration of free AMC to quantify moles of AMC released into solution.

3. The method of claim 2 wherein the known concentration of free AMC is between 5 nM and 5 mM.

4. The method of claim 1 wherein the protein substrate is a purified proteolytic enzyme.

5. The method of claim 1 wherein the protein substrate is obtained from cell lysates or cell extracts.

6. The method of claim 1 wherein the protein substrate has a molecular weight from about 10 kDa (kilodalton) of about 300 kDa.

7. The method of claim 1 wherein the protein substrate is selected from the group consisting of bovine serum albumin (BSA), catalase, hemoglobin, and superoxide dismutase.

8. The method of claim 1 wherein the test solution has a pH from about 2 to about 11.

9. The method of claim 4 wherein the proteolytic enzyme is present in an amount from about 320 nM to about 1 mM of the test solution.

10. The method of claim 1 wherein the protein substrate is present in the test solution in an amount from about 25 ng per milliliter to about 0.5 μg per milliliter.

11. The method of claim 1 wherein greater than 50 percent of the protein fragments are smaller than 500 Da.

12. The method of claim 4 wherein the proteolytic enzyme is selected from the group consisting of pepsin, proteinase K, trypsin, and chymotrypsin.

13. The method of claim 1 wherein the fluorescence is initiated by excitation with light having a wavelength from 360 to 420 nanometers.

14. The method of claim 13 wherein the fluorescence is measured at a wavelength from about 430 to about 450 nanometers.

15. The method of claim 14 wherein the fluorescence is measured at a wavelength of about 444 nanometers.

16. The method of claim 12 wherein the fluorescence is measure at a predetermined time interval.

17. A method for measuring degradation of intact proteins, the method comprising:

a) reductively attaching coumarin derivative to a protein substrate with a reducing agent, the reducing agent being sodium cyanoborohydride (NaCNBH 3 ) the coumarin derivative having the following formula:

wherein:

R 1 , R 2 are each independently hydrogen, C 1-10 alkyl, C 1-10 alkoxy, C 3-10 amide, C 4-10 diamide, C 3-10 ester, C 4-10 diester, C 6-10 aryl, or C 6-10 heteroaryl;

R 3 , R 4 are each independently hydrogen, C 1-10 alkyl, C 1-10 alkoxy, C 2-10 carboxy, C 3-10 amide, C 4-10 diamide, C 3-10 ester, C 4-10 diester, C 6-10 aryl, or C 6-10 heteroaryl; and

R 5 , R 6 are each independently hydrogen or C 1-5 alkyl;

b) contacting in a test solution the protein substrate with a proteolytic enzyme that degrade the protein substrate into protein fragments; and

c) measuring fluorescence during degradation of the protein substrate.

18. The method of claim 17 wherein R 5 , R 6 are each independently hydrogen.

19. The method of claim 18 wherein R 1 is C 1-10 alkyl, C 1-10 alkoxy, or C 1-10 perfluoroalkyl and R 2 , R 3 , R 4 are hydrogen.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 31, 2024
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 068219/0651 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2012
From: DAVIES, KELVIN J. A.; PICKERING, ANDREW M.
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 029293/0263 →
Continuity (2)
Provisional Application 61529381 · Aug 31, 2011
Related Publication 20130059321A1 · Mar 7, 2013